SE7503391L - - Google Patents

Info

Publication number
SE7503391L
SE7503391L SE7503391A SE7503391A SE7503391L SE 7503391 L SE7503391 L SE 7503391L SE 7503391 A SE7503391 A SE 7503391A SE 7503391 A SE7503391 A SE 7503391A SE 7503391 L SE7503391 L SE 7503391L
Authority
SE
Sweden
Application number
SE7503391A
Other versions
SE419987B (sv
Inventor
S Yurugi
S Kikuchi
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of SE7503391L publication Critical patent/SE7503391L/xx
Publication of SE419987B publication Critical patent/SE419987B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • C07D213/85Nitriles in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7503391A 1974-03-25 1975-03-24 Analogiforfarande for framstellning av 7-(hydroxifenyl)pyrido(3,4-d)-pyridaziner SE419987B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP49033679A JPS5811874B2 (ja) 1974-03-25 1974-03-25 ピリド (3,4−d) ピリダジンルイノ セイゾウホウ

Publications (2)

Publication Number Publication Date
SE7503391L true SE7503391L (xx) 1975-09-26
SE419987B SE419987B (sv) 1981-09-07

Family

ID=12393114

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7503391A SE419987B (sv) 1974-03-25 1975-03-24 Analogiforfarande for framstellning av 7-(hydroxifenyl)pyrido(3,4-d)-pyridaziner

Country Status (15)

Country Link
US (1) US4005201A (xx)
JP (1) JPS5811874B2 (xx)
AT (1) AT342064B (xx)
BE (1) BE827103A (xx)
CA (1) CA1044234A (xx)
CH (1) CH597229A5 (xx)
DE (1) DE2512673A1 (xx)
DK (1) DK134554B (xx)
ES (1) ES435955A1 (xx)
FR (1) FR2265384B1 (xx)
GB (1) GB1503032A (xx)
HU (1) HU169631B (xx)
NL (1) NL7503289A (xx)
NO (1) NO141852C (xx)
SE (1) SE419987B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2056142A1 (en) * 1990-11-27 1992-05-28 Hirotomo Masuya Pyridopyridazine compounds and their use
DE19500760A1 (de) * 1995-01-13 1996-07-18 Basf Ag Substituierte 2-Phenylpyridine
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
MXPA03011558A (es) 2001-06-12 2004-03-26 Wellstat Therapeutics Corp Compuestos para el tratamiento de desordenes metabolicos.
JP2009511629A (ja) * 2005-10-17 2009-03-19 ニューロセラピューティクス ファーマ, インコーポレイテッド 中枢神経系疾患の調節に有用な利尿薬様化合物類似体
CN108484494B (zh) * 2018-06-15 2021-07-30 沈阳药科大学 2-氧代-1,2-二氢吡啶-4-甲酸类化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793345A (fr) * 1971-12-28 1973-06-27 Takeda Chemical Industries Ltd Derives de pyridopyridazine

Also Published As

Publication number Publication date
CA1044234A (en) 1978-12-12
AU7944875A (en) 1976-09-30
DK123975A (xx) 1975-09-26
JPS50129594A (xx) 1975-10-13
DK134554B (da) 1976-11-29
BE827103A (fr) 1975-09-24
FR2265384B1 (xx) 1980-01-18
DE2512673A1 (de) 1975-10-02
NL7503289A (nl) 1975-09-29
JPS5811874B2 (ja) 1983-03-04
NO141852B (no) 1980-02-11
GB1503032A (en) 1978-03-08
HU169631B (xx) 1976-12-28
US4005201A (en) 1977-01-25
ATA214775A (de) 1977-07-15
NO750939L (xx) 1975-09-26
AT342064B (de) 1978-03-10
SE419987B (sv) 1981-09-07
CH597229A5 (xx) 1978-03-31
FR2265384A1 (xx) 1975-10-24
ES435955A1 (es) 1977-01-01
NO141852C (no) 1980-06-04
DK134554C (xx) 1977-05-02

Similar Documents

Publication Publication Date Title
FR2262672B1 (xx)
FR2260116A1 (xx)
DK433275A (xx)
DK134554C (xx)
JPS50111397U (xx)
JPS50117363U (xx)
JPS50147032U (xx)
JPS50129595A (xx)
JPS50138677U (xx)
JPS4947392Y1 (xx)
JPS50142536U (xx)
JPS50108768A (xx)
JPS50106890A (xx)
IN142572B (xx)
JPS50115898U (xx)
CH583955A5 (xx)
CH580484A5 (xx)
CH585442A5 (xx)
CH583833A5 (xx)
CH583799A5 (xx)
CH577818A5 (xx)
CH577934A5 (xx)
CH583320A5 (xx)
CH583329B5 (xx)
CH581767A5 (xx)